Navigation Links
ShangPharma Announces Second Quarter 2011 Results

econd quarter of 2010, primarily due to higher non-GAAP profit from operations, which was partially offset by lower other income.  

Diluted earnings per ADS were $0.18, which compares with $0.26 in the second quarter of 2010.  

Non-GAAP diluted earnings per ADS were $0.25, which compares with $0.28 in the second quarter of 2010.

Financial Position  As of June 30, 2011, the Company had cash and cash equivalents of $41.6 million and short term debt of $0.8 million. During the quarter, capital expenditures totaled $11.0 million, including $5.5 million related to the purchase of a 68,000 square foot new lab and office building which replaced the original 36,000 square foot facility in Chengdu. The purchased lab and office building allows us to reduce overall expenditures and improve our earnings over time.  With a strong balance sheet and sound financial position, the Company is well positioned to make targeted investments when opportunities arise.  

Full Year 2011 GuidanceThe Company reconfirms its guidance for full year 2011.  The Company expects:

  • Net revenues to be approximately $111.1 – $115.6 million, which represents growth of approximately 23.0% – 28.0% compared with full year 2010.  
  • Non-GAAP gross margin to be approximately 33.5% – 35.5%, which is within the same range as non-GAAP gross margin of 34.5% in 2010.
  • Capital expenditure to be $28 - $32 million, including $6 million rolling payment lag impact carried forward from 2010.

  • This reflects the Company's current view and is subject to change.

    Conference CallShangPharma will host a conference call and live webcast at 8am New York time on August 22, 2011 (8pm Beijing time on August 22, 2011).  A PowerPoint presentation accompanying the prepared remarks will be available on the Company's website shortly before the call.  

    The dial-in details

    SOURCE ShangPharma Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related biology technology :

    1. ShangPharma Corporation Named a Top Ten Chinese Outsourcing Enterprise
    2. ShangPharma Announces First Quarter 2011 Results
    3. ShangPharma Corp. to Announce Fourth Quarter and Full Year 2010 Financial Results on March 15, 2011
    4. Stem Cell Assurance, Inc. Announces Change of Name to BioRestorative Therapies, Inc.
    5. Syndax Pharmaceuticals Announces Issuance of EU Patent for Entinostat
    6. Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA
    7. ACMG Announces New Online Live Learning Center: Will Bring Genetics and Genomics Education to Varied Health Professionals
    8. Neurologix Announces Second Quarter 2011 Financial Results
    9. Bion Announces New U.S. Patent for Phosphorus Removal
    10. ViaCyte Announces Executive Management Changes
    11. NeoStem Announces the Receipt of Over $1,700,000 in DOD Funding for its VSEL™ Technology Being Developed to Treat Osteoporosis
    Post Your Comments:
    (Date:12/19/2014)... In contrast to traditional LED lights where the ... uses proprietary LED technology to incorporate their spectra in ... is critical in low proximity installations. The Valoya L-series ... lifetime which is up to four times longer than ... cost was clearly higher when compared to traditional fluorescent ...
    (Date:12/19/2014)... (PRWEB) December 18, 2014 With only ... time special on Sartorius Biohit products . The ... mLINE pipettes, Picus Electronic Pipette Trade-in Program, and free ... and Safety officers around the world. They are ideal ... Other features include:, ,     Full volume range ...
    (Date:12/19/2014)... Dec. 18, 2014 Egenix, Inc. is pleased to ... Chairman of the Board, to succeed Donald Fresne ; ... will continue as a member of the Board.  In recognition ... to the company over almost twenty years, the Board designated ... of Directors has established a Search Committee to find a ...
    (Date:12/19/2014)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company ... announced the results of its annual general meeting of ... year in Relmada,s history and it set the stage ... Sergio Traversa , chief executive officer of Relmada. "Over ... human resource and clinical development objectives that position Relmada ...
    Breaking Biology Technology:Major Pipette Distributor Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2
    ... International, Inc. (OTCQX: DATA), a technology and services company ... industry, today announced the Company,s selection as a 2011 ... year. "Being once again recognized as ... dedication DATATRAK and its employees have to bringing a ...
    ... In the computer displays of medical equipment in ... a major role. But a discovery reported from the ... crystal, which have been found to change their ordering ... very low concentrations of a particular bacterial lipid, might ...
    ... Switzerland, May 20, 2011 Syngenta announced today that ... facility adjacent to its existing research campus in Research ... is scheduled to begin in June 2011, will focus ... innovative solutions to growers across the world.   ...
    Cached Biology Technology:DATATRAK Recognized as 2011 Crain's Leading EDGE Award Winner 2Liquid crystal droplets discovered to be exquisitely sensitive to an important bacterial lipid 2Liquid crystal droplets discovered to be exquisitely sensitive to an important bacterial lipid 3Syngenta to Invest in New U.S. Genetics Research Facility 2
    (Date:12/4/2014)... GARDENS, Fla. , Dec. 3, 2014 /PRNewswire/ ... solutions, today announced that its DigitalPersona ® ... fingerprint readers have been deployed throughout First Bank ... , South Carolina and ... in Southern Pines, North Carolina ...
    (Date:11/21/2014)... , November 18, 2014 According ... Market by Systems (Video, RFID, Access Control, Intrusion Detection, ... Hotels, Banks, Government), Component Service Geography - Global Forecasts ... Market is projected to be around $25 Billion in ... 2020, growing at a CAGR of 8.69%. ...
    (Date:11/21/2014)... C-Labs LLC, a leading provider of remote ... today announced the appointment of John Traynor ... strategic advisor to the firm, Mr. Traynor will now ... based out of the C-Labs office in ... Muench , Chief Executive Officer. Photo - ...
    Breaking Biology News(10 mins):First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Industrial Security Systems Market Worth $38 Billion by 2020 2Industrial Security Systems Market Worth $38 Billion by 2020 3C-Labs Names Former Microsoft and Bsquare Executive as Chief Operating Officer 2
    ... Today, farming often involves transporting crops long distances ... corn, Northwest cherries and other produce when they are ... fossil fuel needed to move food that contributes to ... journal Biogeosciences provides a detailed account of how carbon ...
    ... Water, an increasingly critical resource in the world, factors ... of "Turfgrass Water Conservation," a widely used reference, was ... and water conservation has made significant gains. Now ... the reference book to bring readers, attention to the ...
    ... Seeking to measure the U.S. first responder community,s ... local levels, the National Institute of Standards and Technology ... will distribute documentary standards to first responders as part ... October 2011. The pilot will help OLES gauge whom ...
    Cached Biology News:Carbon hitches a ride from field to market 2Carbon hitches a ride from field to market 3Carbon hitches a ride from field to market 4How to manage turfgrass while conserving water 2It's your standard pilot project: NIST to offer documentary standards to first responders 2
    EGTA, 50 g. Ethylene glycol-O,O-bis-[2-amino-ethyl]-N,N,N,N,-tetraacetic acid.Assay: > 99.0%. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
    RAT ANTI RAT RT1Au (CLASS I POLYMORPHIC) Immunogen: AO lymphoid cells...
    Request Info...
    Human VEGF R Phycoerythrin Sampler (Cl 89106, 49560, 54733)...
    Biology Products: